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1. Introduction 
Diabetes mellitus is a group of metabolic disorders of carbohydrate metabolism in which 
glucose is underutilized, producing hyperglycemia. The disease is classified into several 
categories. The revised classification, published in 1997 (ADA, 1997; The Expert Comitee on 
the Diagnosis and Classification of Diabetes mellitus, 2000), defines Type 1 diabetes mellitus 
(formerly known as the insulin-dependent diabetes mellitus or juvenile-onset diabetes 
mellitus) as a disorder caused by autoimmune destruction of pancreatic h-cells, rendering 
the pancreas unable to synthesize and secrete insulin. In 85–90% of cases, antibodies appear 
against pancreatic h-cells (ICA), acting as anti-insulin (IAA), or others such as GAD, IA-2 
and IA-2h (Geiss et al 1997). 
The latter complications of diabetes mellitus include both microvascular complications 
(predominantly retinopathy, nephropathy and neuropathy) and macrovascular 
complications, particularly stroke and coronary artery disease. Together, these make 
diabetes the seventh most common cause of death in the developed world (Geiss et al 1997). 
The major microvascular complications, retinopathy and nephropathy, are the more 
important causes of blindness and end-stage renal disease in Europe. There are few 
similarities in the coexistence of DR and DN being both as microvascular disease and 
microscopically both have capillary basement membrane thickening. However, capillary 
closure is apparent in the retina and kidney after sufficient exposure to disease with 
duration. The pathophysiology of DN and DR are more or less similar, which commence 
with increase in vascular permeability. The selective increase in permeability to albumin in 
early DN is caused by loss of polarity across the glomerular basement membrane (Myers et 
al, 1982) and the disease mechanism in the eye is probably a breakdown of tight junctions 
between cells. The onset of proteinuria and proliferative retinopathy are both related to 
previous poor glycemic control, duration of diabetes and hypertension. 
The detection of retinopathy is easy (by the use of fundus periodical retinographies), but the 
diagnosis of the early stages of nephropathy needs microalbuminuria to be determined in 
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urinalysis. Microalbuminuria has prognostic significance; thus, in 80% of people with Type 
1 diabetes mellitus and microalbuminuria, urinary albumin excretion increases at a rate of 
10–20% per year, with the development of clinical proteinuria within 10– 15 years.  After the 
development of clinical grade proteinuria (>80%), patients go on to develop decreased 
glomerular filtration rate and, given enough time, end-stage renal disease (Geiss et al 1997). 
Several factors appear to influence susceptibility to the microvascular complications of 
diabetes mellitus, but our knowledge of the role and the importance of these genetic and 
environmental factors are still incomplete. The most powerful risk factor for microvascular 
complications was the duration of diabetes, but frequency of both retinopathy and 
nephropathy was impressively related to the level of plasma glucose at the time of 
examination. 
From the recent studies, it is evident that the presence of retinopathy itself may reveal 
patients at risk for nephropathy (Estacio et al, 1998; El Asrar et al, 2002; Rossing et al, 2002; 
Villar et al, 1999). In a cross sectional study, patients with DR were 5.68, 13.39 and 3.51 times 
as likely to have DN among type1 and type2 diabetic patients (El-Asrar et al, 2002). 
However, there is lack of evidence that determine the association of retinal-renal 
complications using the gold standard methods. The DR is characterized by microvascular 
abnormalities, proliferation of retinal vessels and increased retinal vascular permeability 
leading to the development of non-proliferative and proliferative DR, and macular edema 
(Williams et al 2004). The DN is a life threatening complication which predisposes to excess 
morbidity and mortality resulting from renal failure and cardiovascular disease (Ritz et al, 
1999; Adler at al, 2003). 
Our hypothesis was that the severity of DR correlates with the presence and severity of 
DN in people with type 1 diabetes. Studies in other populations documented a well-
known association between advanced DR stages and overt nephropathy in type 1 diabetic 
patient (Looker et al, 2003; Gall et al, 1997). Similarly, our results provide further support 
to the close relationship between presence of DR and severity of DN in type1 diabetic 
patients. 
It was reported that at least one fifth of the diabetic individuals are affected by multiple 
complications and the frequency increases with increasing age and duration of diabetes.  
In the study of WESDR, there was a strong correlation between DN and severity of DR in all 
age groups (Klein et al, 1984; Klein et al 1984). 
In the present study we determine the epidemiological risk factors that influence the 
appearance of diabetic retinopathy, and overt nephropathy, in a seventeen -year follow-up 
of a population sample of 112 patients who did not have diabetic retinopathy or 
microalbuminuria at the beginning of the study. 
2. Methods 
2.1 Sample size and study population 
Since 1987 a register has been kept of any new cases of type I diabetes mellitus in Catalonia 
(Spain). The incidence of new cases over that period has been 11.4 cases per 100000 
inhabitants (13.2 cases in men and 9.6 cases in women) (Castell et al, 1999). 
Since 1990, there has been an ongoing registration of all diabetic patients (type I and 2) at St 
Joan Hospital, which is the only surgical ophthalmology centre in Reus (Spain), and having 
a dependent population of around 207,500 inhabitants. In 1999, there were 1495 patients 
with diabetes mellitus type I (Castell et al, 1999). 
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2.2 Design 
The present study is prospective and was initiated in 1990 with 126 patients recruited with 
type I diabetes mellitus. The initial conditions included the absence of retinopathy and 
nephropathy (determined by the absence of microalbuminuria in three consecutive 
measures taken at one month intervals).  
Two previous results were obtained at 5 and 10 years of the study (Romero-Aroca et al, 
2000; Romero-Aroca et al, 2003). At the end of the study in 2007 only 112 patients were still 
being controlled (14 patients had dropped out during the follow up). At the end of the study 
(seventeen years of follow-up) the authors have determined the incidence of diabetic 
macular oedema and their risk factors, related to the appearance of renal overt nephropathy. 
2.3 Diagnostic methods 
Diabetic retinopathy was evaluated by retinal photographs through dilated pupils, of two 
50º fields of each eye centred firstly at the temporal to the macula and secondly at the nasal 
to the papilla (Aldington et al, 1995 ). The results were then classified into four groups 
(Wilkinson et al 2003):  
 Mild non proliferative 
 Moderate non proliferative 
 Severe non proliferative 
 Proliferative  
Macular edema was diagnosed under stereoscopic viewing of the macula with a slit lamp 
and Goldmann fundus contact lens, and was considered present if we found: 
 retinal thickening involving or within 500 μ m of the centre of the macula 
 hard exudates at or within 500 μ m of the centre of the macula, if associated with 
thickening of adjacent retina (but no hard exudates remaining after retinal thickening 
disappeared) 
 a zone or zones of retinal thickening, one disc area or larger in size, any part of which is 
within 1 disc diameter of the centre of the macula. 
The clinical classification used was the international clinical diabetic retinopathy disease 
severity scale, proposed by the American Academy of Ophthalmology in 2002 (Wilkinson et 
al 2003). In all patients with diabetic macular oedema, a fluorescein angiography was 
obtained, centred on macular region to determine the leakage in that area. The fluorescein 
angiographic findings were categorized into three types:  
 focal leakage type, which was predominantly well-defined focal areas of leakage from 
microaneurysm or localized dilated capillaries;  
 diffuse leakage type, predominantly widespread and ill-defined leakage involving the 
whole circumference of the fovea;  
 cystoid leakage type, predominantly diffuse leakage but with pooling of dye in the 
cystic spaces of the macula in the late phase. 
Since 2000, all patients with diabetic macular oedema have been given an optical coherence 
tomography OCT), repeated every 4 months as a control test.  Optical coherence 
tomography was performed with a OCT model TOPCON TRC NW 7SF. The retinal map 
algorithm uses measurements along 6 radial lines, 6 mm in length, to produce a circular plot 
in which the foveal zone is the central circular zone of 1.00 mm in diameter. Macular edema 
measured by OCT was defined as a retinal thickening of more than 216 microns, and was 
classified as follows, using the Otani et al patterns amplified by the two tractional forms 
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described later (Otani et al, 1999 ): Sponge-like retinal thickness, defined as increased retinal 
thickness with reduced intra retinal reflectivity and expanded areas of lower reflectivity; 
cystoid macular oedema, characterized by the intra retinal cystoid spaces at the macular 
area; serous retinal detachment was thought to be present if the posterior surface of the 
retina was elevated above the outer border of the highly reflective band, regarded as the 
signal generated mainly by the retinal pigment epithelium. Only patients with a visible 
separation between the layer of photoreceptors and the pigment epithelium, was classified 
as serous detachment; if we observed the photoreceptor layer adjacent to pigment 
epithelium, we classified the case as cystoid macular oedema. 
2.4 Inclusion criteria  
Patients with type I diabetes mellitus (insulin dependent or young-onset diabetes mellitus) 
2.5 Exclusion criteria 
Presence of diabetic retinopathy at the beginning of study, presence of diabetic nephropathy 
at the beginning of study, presence of microalbuminuria at the beginning of study, patients 
with LADA diabetes (latent autoimmune adult diabetes), patients with type 2 diabetes 
mellitus (not insulin-dependent or older-onset diabetes mellitus), patients with type 2 
diabetes mellitus appeared before 30 years of age (MODY diabetes mellitus) 
2.6 Definition of variables 
Visual acuity in each eye was measured on the Snellen chart and recorded as a decimal 
value, with best refraction for distance. All data manipulations were performed on visual 
acuities expressed in log MAR form. The legal blind subject was defined as corrected visual 
acuity less than or equal to 0.1 in the better eye; reduced visual acuity as less than or equal 
to 0.4 and greater than 0.1 in the better eye. 
The epidemiological risk factors included in the study were: 
 Gender and current age. 
 Duration of diabetes mellitus, classified in the statistical study in two groups: below 20 
years of duration and equal to or more than 20 years duration. 
 Type of diabetic retinopathy classified into two groups: first with a diabetic retinopathy 
lower than severe pattern, and the second with patients with severe or proliferative 
pattern, patients who need scattered photocoagulation were classified in tis second 
group. 
 Arterial hypertension, which indicates a systolic measurement above or equal to 140 
mm Hg and the diastolic measurement above or equal to 90 mm Hg, or when the 
patient is taking anti-hypertensive medications.  
 Levels of glycated haemoglobin (HbA1c) as recommended i by the American Diabetes 
Association (ADA, 1997) as the major component of HbA1c (accounting for 80% of 
HbA1c), was measured every 3 months. The control of glycaemia was considered in 
concordance with the European Diabetes Policy Group, into two groups of patients i.e. 
over or under 7.0% (European Diabetes Policy Group, 1999). The value included in the 
statistical analysis was the mean of all values obtained over the 15 years. 
 Presence of microalbuminuria, defined as increased albumin excretion (30-300 mg of 
albumin/24 h or 20-200 µg/min of creatinine) on two of three tests repeated at intervals 
of 3-6 months as well as exclusion of conditions that invalidate the test (Geiss et al, 
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1997). The test was performed annually. After  microalbuminuria was diagnosed, 
repeated testing was made within a period of 3-4 months. 
 Presence of diabetic nephropathy, defined as clinical albuminuria or overt nephropathy 
by the American Diabetes Association, corresponding to protein excretion >300 mg/24h 
(>200 µg/min or >300 µg/mg of albumin: creatinine ratio). Measurement of creatinine 
clearance as an index of glomerular filtration rate was performed on the same urine 
collection (Geiss et al, 1997). 
 Patients were classified as having macro vascular disease if one or more of the 
following were present: symptoms of angina pectoris, history of myocardial infarction, 
coronary artery by pass grafting, percutaneous tranluminal coronary angioplasty, 
symptoms of or operation for intermittent claudication, history of amputation, transient 
ischemic attack, stroke. 
 Levels of triglycerides and fractions of cholesterol (HDL-cholesterol and LDL-
chorlesterol). In the statistical analysis, we classified the patient into normal or higher 
values, according to the ADA categories as patients with high risk if LDL-cholesterol 
3.35 mmol/L (130 mg/dl), HDL-cholesterol 0.90 mmol/L for men and >1.15 mmol/L 
for women (35 mg/dL for men and 45 mg/dL for women), and triglycerides  1.5 
mmol/dL (400 mg/dL), (Expert Panel on Detection, Evaluation, And Treatment of high 
Blood Cholesterol in Adults, 2001). 
2.7 Statistical methods 
All statistical analyses were carried out using the SPSS software package (version 18.0), 
results are expressed as mean±standard error, a P-value of less than 0.05 was considered to 
indicate statistical significance. 
Differences between those included in analyses were examined using the two sample 
Student T-tests or one-way ANOVA, for continuous or quantitative data, as visual acuity or 
current age. For the qualitative or categorical data we used the Chi-square test in the 
univariate phase of study, with determination of Odds ratio for each variable.  
The Kruskal-Wallis test and the least significant difference test using ranks for multiple 
comparisons were carried out to evaluate the correlation between best-corrected visual 
acuity an OCT findings. 
In the multivariate phase of analysis the relationship of diabetic retinopathy, 
microalbuminuria and overt nephropathy, to various demographic and other risk factors 
were examined using logistic regression analysis; the full model was built including gender 
and age a priori. 
3. Results 
Demographic variables of the patients  
Gender: 54 patients were men (48.2%) and 58 were women (51.8%) 
The mean of age was 39.94  10.53 years old (24 – 61 years), the mean of diabetes mellitus 
type I duration was 23.42  7.57 years (12 – 45 years). The arterial hypertension was present 
in 44 patients (39.3%). 
The means of the different quantitative data were: 
 Glycosylated haemoglobin A1c: 7.69%  1.24 (4.50% – 11.40%) 
 LDL-Cholesterol: 3.50  0,57 mmol/l (3.00 – 4.00) 
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 HDL-Cholesterol: 1.12  0,42 mmol/l (0.70 – 2.02) 
 Triglycerides: 1.47  0.76 mmol/l  (0.90 – 3.00) 
Visual acuity study 
Mean visual acuity after 17 years was 0.77  0.34 ( 0,02 – 1) in the Snellen chart test; and 
+0.37  +0.72 (+ 1.7 - + 0) in the Log MAR test. 
Low vision (defined as vision in the best eye >0,1 and < 0.4 in the Snellen chart) was 
detected in 13 patients (11.6%) and blindness (AV < 0.1 in Snellen chart) in 14 patients 
(12.5%). 
Incidence of diabetic retinopathy (Table 1) 
After 17 years there were 62 patients (55.4%) with different types of diabetic retinopathy. 
The Rate of progression was 8.30 person-year. 
 Mild diabetic retinopathy in31 patients (27.7%) 
 Moderate diabetic retinopathy in 7 patients (6.3%) 
 Severe diabetic retinopathy in 5 patients (4.5%) 
 Proliferative diabetic retinopathy in 18 patients (16.1%) 
There were 23 patients (20.5%) with diabetic macular edema after 17 years, the Rate of 
progression was 3.08 person-year. The mild or moderate form of diabetic macular edema 
was present in 13 patients (11.6%) and the severe form of macular edema in 10 patients 
(8.9%). 
In the 62 patients with diabetic retinopathy 17 (27.42%) developed overt nephropathy, with 
a rate of progression 4.11 person-year. In patients with proliferative form of diabetic 
retinopathy (23 patients) 11 developed microalbuminuria (47.82%), the rate of progression 
was 7.17 person-year. 
Statistical study of diabetic retinopathy 
Univariate study with the application of chi squared test (Table 1). 
The factors significant in the appearance of diabetic retinopathy were as follows: duration of 
diabetic retinopathy p<0.001, presence of arterial hypertension p<0.001, levels of glycated 
haemoglobin (HbA1c) > 7.5% p<0.001, high levels of LDL-cholesterol p<0.001, high levels of 
tryglicerides p=0.003 and presence of overt nephropathy p= 0.001. 
Logistic regression of diabetic retinopathy (Table 2). 
The followings factors studied were significant in the appearance of diabetic retinopathy: 
Duration of diabetes mellitus more than 20 years p< 0.001, presence of arterial hypertension 
p<0.001, high levels of HbA1c p< 0.001, high levels of tryglicerides p=0.004, high levels of 
LDL-Cholesterol p= 0.002, and overt nephropathy p=0.021. 
Statistical study of diabetic nephropathy 
Univariate analysis with the application of chi squared test(Table 1). 
The factors significant in the apparition of overt nephropathy were: presence of arterial 
hypertension p<0.001, high levels of HbA1c p<0.001, high levels of LDL-Cholesterol p=0.010, 
high levels of triglycerides p=0.003, and presence of diabetic retinopathy p=0.021. When we 
introduced the presence of proliferative diabetic retinopathy against the presence of any 
retinopathy, the chi squared test had a result of p<0.001, and for proliferative diabetic 
retinopathy p< 0.001. 
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Logistic regression of diabetic nephropathy (Table 2). 
The significant factors were: the presence of arterial hypertension p<0.001, and high levels of 
HbA1c p<0.001, high levels of LDL-Cholesterol p=0.002, high levels of triglycerides p=0.009,. 
Also the presence of diabetic retinopathy was significant  p=0,021. When we introduced the 
presence of proliferative diabetic retinopathy against the presence of any retinopathy, the 
chi squared test had a result of p<0.001 
 
 Diabetic retinopathy Overt Nephropathy 
Risk factor Chi square 
Logistic 
regression 
Chi square Logistic regression 
 
Signifi-
cance 
(p) 
Odds 
ratio 
Signifi
cance 
(p) 
Odds 
ratio 
Signifi-
cance 
(p) 
Odds 
ratio 
Signifi-
cance 
(p) 
Odds 
ratio 
Gender 0.237 1.397 0.829 0.881 0.743 0.107 0.870 0.910 
Glycated 
haemoglobin 
(HbA1c) >8%) 
<0.001 11.011 <0.001 5.575 <0.001 55.687 <0.001 38.360 
Arterial 
hypertension 
<0.001 28.193 0.007 6.579 <0.001 12.777 0.023 10.271 
Duration of 
diabetes 
mellitus  
(20 years) 
<0.001 33.623 <0001 12.096 0.913 0.012 0.170 0.394 
HDL-
Cholesterol 
0.828 0.047 0.813 0.837 0.019 5.201 0.061 0.195 
LDL-
Cholesterol 
<0001 18984 0.002 10.304 0.010 2.715 0.002 3.555 
Triglycerides 0.003 8.442 0.004 1.528 0.003 3.513 0.009 2.912 
Overt 
Nephropathy 
0.001 6.097 0.021 3.498     
Retinopathy     0.021 6.097 0.021 2.153 
Proliferative 
diabetic 
retinopathy 
    <0.001 14.814 <0.001 4.306 
Table 1. Chi squared and logistic regression analysis for diabetic retinopathy and 
microalbuminuria. 
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Patients only with 
retinopathy 
Patients only with overt 
nephropathy 
Patients with retinopathy and 
overt nephropathy 
Duration of diabetes 
mellitus (4.679)* 
High levels of HbA1c 
(7.250)* 
High levels of HbA1c (6.471)* 
High levels of HbA1c 
(2.250)* 
High levels of triglycerides 
(1.713)* 
High levels of triglycerides 
(2.810)* 
Arterial hypertension 
(2.668)* 
Duration of diabetes 
mellitus (1.029)* 
Arterial hypertension (2.657)* 
High levels of LDL-
cholesterol (1.277)* 
Arterial hypertension 
(0.742)* 
Duration of diabetes mellitus 
(2.269)* 
High levels of triglycerides 
(1.254)* 
High levels of LDL-
cholesterol (-1.360)* 
High levels of LDL-cholesterol 
(1.232)* 
* = Function of classification coefficients. 
Table 2. Fisher’s classification coefficient. 
Statistical application of discriminate analysis 
At the end of the study we may observe that four groups of patients had been formed:  
 those without any form of microangiopathy (overt nephropathy or retinopathy) 45 
patients (group A). 
 those with only retinopathy (45 patients) (group B). 
 those with only overt nephropathy (5 patients) (group C). 
 those with both overt nephropathy and retinopathy (17 patients) (group D). 
In this case we needed to apply a discriminate analysis to evaluate the risk factors for the 
different groups. 
Applying Fisher’s coefficient indicated that (Table 2): 
 for group B the risk factors were: duration of diabetes mellitus (4.679), high levels of 
HbA1c (2.250) and high levels of LDL-Cholesterol (2.268) 
 for the group C only the high levels of HbA1c (7,250) were highly correlated 
 for the group D the significant factors were: high levels of HbA1c (6,471), presence of 
arterial hypertension (2.657), high levels of triglycerides (2.810) and duration of diabetes 
mellitus (2.269) 
4. Discussion 
The diabetic retinopathy (DR) and diabetic nephropathy (DN) are the two major 
complications of diabetes mellitus. The proliferative diabetic retinopathy and proteinuria 
secondary to DN are both late complications of diabetic overt nephropathy, these usually 
occur 10 to 15 years after the onset of type 1 DM, and are strongly associated with each 
other. The epidemiology of diabetic overt nephropathy and retinopathy in type 1 DM, are 
different, thus for diabetic overt nephropathy increases its prevalence since 10% at ten year 
duration of diabetes mellitus, achieving the highest value after 40 years with a 40% of 
diabetic patients with nephropathy, since this point the curve levels off, and only a minority 
of patients develop clinically significant renal abnormalities, and patients who survive 35 
years of type 1 DM without developing DN are at extremely low risk of doing so in the 
future. Against this curve the diabetic retinopathy succeed in a different form in type 1 
diabetic patients, thus the diabetic retinopathy is rare before 10 years DM duration, and 
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increases the prevalence, since this point to a levels upper 80% after 20 years diabetes 
duration, without a decreases after these 20 years of duration, as we observed in our study. 
The incidence of DR was 55.4%, and was lower than in other studies such as Klein et al 1998 
(Klein et al, 1998), but this may be because the sample studied did not present diabetic 
retinopathy at the beginning and patient controls were stricter than in the rest of the patients 
with diabetes mellitus type I (controls every 3 months), we could concluded that the mean 
level of HbA1c  was 7.69%  1.24 (4.50% – 11.40%) is better than the achieved by WESDR 
(Klein et al, 1998). The diabetic macular edema appeared in 20.5% of patients, which was 
more similar to the findings in the Klein study at 14 years (26%). In the present study the 
incidence of diabetic macular edema is higher than the proliferative form of diabetic 
retinopathy in type I diabetes mellitus patients, as was observed in other studies. 
With regard to nephropathy diabetes accountings for more than 19.6% of all cases of DN. 
The DN presents initially as intermittent microalbuminuria that progresses to persistent 
microalbuminuria, and is accompanied by a decline in the glomerular filtration rate. These 
dates were in agreement with other studies published in our country on renal failure in 
diabetes mellitus type I patients Smatjes et al (Esmatjes et al, 1998) found an incidence of 
44.5% with some form of renal failure at 20 years in type I diabetes mellitus. 
The relationship between DN and DR was well described, thus the Wisconsin 
Epidemiologic Study of Diabetic Retinopathy (Klein et al, 1993) associated the presence of 
gross-proteinuria at baseline examination with a 96% increase in the risk of progression to 
proliferative retinopathy. Also in the Steno study (Kofoed-Enevoldsen et al, 1987), people 
with type I diabetes mellitus and gross-proteinuria at baseline had an increase risk of 
progression to proliferative retinopathy (12% annually) compared to those without 
proteinuria (1%-2% annually).  
At the end of our study we can see that four groups of patients had formed: those without 
overt nephropathy or diabetic retinopathy (45 patients), patients with only overt 
nephropathy (5 patients), those with only diabetic retinopathy (45 patients), and those with 
overt nephropathy and diabetic retinopathy (17 patients). The statistical test used for 
examining these data was a discriminate test, which allowed us to identify the risk factors 
that influence any of these groups.  
In the group of patients with only DR the duration of diabetes mellitus was the more 
important risk factor and for the group with Dr and DN the most important risk factor is the 
high levels of HbA1c.  
We may assume then, that for the development of only retinal lesions in diabetes mellitus, 
the duration of the disease is the most important followed by and in a second level of 
importance the levels of HbA1c and arterial hypertension; and for the development of renal 
and retinal lesion simultaneously poor control of glycaemia measured by levels of HbA1c 
were more important than the duration of diabetes mellitus.  
Two broader groups of patients  can be assumed to have been formed in this study, the first 
being those patients who developed only diabetic retinopathy, and the second those with 
both diabetic retinopathy and renal lesion (overt nephropathy). This conclusion is consistent 
with previous studies as that of Lövestam-Adrian in 1998 (Lövestam-Adrian, et al, 1998), in 
which after a 10-year follow-up of a population of 24 patients, with proliferative diabetic 
retinopathy at the beginning of the study, only two developed microalbuminuria, That 
study concluded that there are, at least partly, different pathogenic mechanisms behind 
diabetic retinopathy and overt nephropathy. 
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5. Conclusion  
Despite there being a poor relationship between overt nephropathy and diabetic retinopathy 
(p=0.021 in the present study), the presence of overt nephropathy correlated well with 
severe forms of diabetic retinopathy (as proliferative Dr p<0.001 in the present study); and 
in addition, at the end of study two broad group of patients had been configured, the first 
those who developed only diabetic retinopathy, and the second  with diabetic retinopathy 
and renal lesion (overt nephropathy).  For the first group with only DR , duration of 
diabetes mellitus is the most important risk factor, and for the second group (patients with 
DR and DN) the levels of HbA1c and blood pressure are the most important. 
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